Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

HLA and glutamic acid decarboxylase in human insulin-dependent diabetes mellitus.

Sanjeevi CB, Falorni A, Kockum I, Hagopian WA, Lernmark A.

Diabet Med. 1996 Mar;13(3):209-17. Review.

PMID:
8689840
2.

Molecular biology of IDDM.

Lernmark A.

Diabetologia. 1994 Sep;37 Suppl 2:S73-81.

PMID:
7821743
3.

[Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].

Hermann R, Gombos Z, Gyürüs E, Soltész G.

Orv Hetil. 2003 Feb 23;144(8):355-60. Hungarian.

PMID:
12666382
4.

ICA12 autoantibodies are associated with non-DR3/non-DR4 in patients with latent autoimmune diabetes in adults from northern India.

Gupta M, Tandon N, Shtauvere-Brameus A, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:329-32.

PMID:
12021135
5.

Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.

Kim J, Namchuk M, Bugawan T, Fu Q, Jaffe M, Shi Y, Aanstoot HJ, Turck CW, Erlich H, Lennon V, Baekkeskov S.

J Exp Med. 1994 Aug 1;180(2):595-606.

6.

Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.

Maioli M, Pes GM, Delitala G, Puddu L, Falorni A, Tolu F, Lampis R, Orrù V, Secchi G, Cicalò AM, Floris R, Madau GF, Pilosu RM, Whalen M, Cucca F.

Eur J Endocrinol. 2010 Oct;163(4):541-9. doi: 10.1530/EJE-10-0427. Epub 2010 Jul 5.

7.

HLA-DQ genotypes are associated with autoimmunity to glutamic acid decarboxylase in insulin-dependent diabetes mellitus patients.

Serjeantson SW, Court J, Mackay IR, Matheson B, Rowley MJ, Tuomi T, Wilson JD, Zimmet P.

Hum Immunol. 1993 Oct;38(2):97-104.

PMID:
8106272
8.

Genetic and immunological findings in patients with newly diagnosed insulin-dependent diabetes mellitus. The Swedish Childhood Diabetes Study Group and The Diabetes Incidence in Sweden Study (DISS) Group.

Kockum I, Lernmark A, Dahlquist G, Falorni A, Hagopian WA, Landin-Olsson M, Li LC, Luthman H, Palmer JP, Sanjeevi CB, Sundkvist G, Ostman IJ.

Horm Metab Res. 1996 Jul;28(7):344-7.

PMID:
8858382
9.

Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.

Pietropaolo M, Becker DJ, LaPorte RE, Dorman JS, Riboni S, Rudert WA, Mazumdar S, Trucco M.

Diabetologia. 2002 Jan;45(1):66-76.

PMID:
11845225
10.
11.

IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.

Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG.

Diabetologia. 1997 Jan;40(1):95-9.

PMID:
9028724
12.

Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.

Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A.

Clin Endocrinol (Oxf). 2000 May;52(5):565-73.

PMID:
10792335
13.

HLA-DR and -DQ gene polymorphism in Latvian patients with insulin-dependent diabetes mellitus.

Shtauvere A, Rumba I, Dzivite I, Sanjeevi CB.

Tissue Antigens. 1998 Oct;52(4):385-8.

PMID:
9820603
14.

Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.

Endl J, Otto H, Jung G, Dreisbusch B, Donie F, Stahl P, Elbracht R, Schmitz G, Meinl E, Hummel M, Ziegler AG, Wank R, Schendel DJ.

J Clin Invest. 1997 May 15;99(10):2405-15.

15.

Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry.

Vandewalle CL, Falorni A, Lernmark A, Goubert P, Dorchy H, Coucke W, Semakula C, Van der Auwera B, Kaufman L, Schuit FC, Pipeleers DG, Gorus FK.

Diabetes Care. 1997 Oct;20(10):1547-52.

PMID:
9314633
16.

Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type.

Hagopian WA, Karlsen AE, Gottsäter A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, Lernmark A.

J Clin Invest. 1993 Jan;91(1):368-74.

17.

Antibodies to glutamic acid decarboxylase are associated with HLA-DR genotypes in both Australians and Asians with type 1 (insulin-dependent) diabetes mellitus.

Serjeantson SW, Kohonen-Corish MR, Rowley MJ, Mackay IR, Knowles W, Zimmet P.

Diabetologia. 1992 Oct;35(10):996-1001.

PMID:
1360432
18.

GAD65 antibody prevalence and association with thyroid antibodies, HLA-DR in Chinese children with type 1 diabetes mellitus.

Chen BH, Chung SB, Chiang W, Chao MC.

Diabetes Res Clin Pract. 2001 Oct;54(1):27-32.

PMID:
11532327
19.

T cell proliferative responses to glutamic acid decarboxylase-65 in IDDM are negatively associated with HLA DR3/4.

Worsaae A, Hejnaes K, Moody A, Ludvigsson J, Pociot F, Lorenzen T, Dyrberg T.

Autoimmunity. 1995;22(3):183-9.

PMID:
8734572
20.

Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.

Tuomi T, Björses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, Miettinen A.

J Clin Endocrinol Metab. 1996 Apr;81(4):1488-94.

PMID:
8636356
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk